Literature DB >> 20231993

Rapid detection of vancomycin-resistant enterococci (VRE) in rectal samples from patients admitted to intensive care units.

Pedro Alves d'Azevedo1, Kelly Aline de Souza Santiago, Guilherme Henrique Campos Furtado, Diego Batista Xavier, Antonio Carlos Campos Pignatari, Ricardo Titze-de-Almeida.   

Abstract

The reduction in time required to identify vancomycin-resistant enterococci (VRE) has gained increased importance during hospital outbreaks. In the present study, we implemented a laboratory protocol to speed up the VRE screening from rectal samples. The protocol combines a medium for selective VRE isolation (VREBAC(R), Probac, São Paulo) and a multiplex PCR for detection and identification of vanA and vanB resistance genes. The screening performance was analyzed in 114 specimens collected from four intensive care units. The swabs were collected at two periods: (1) during a VRE outbreak (February 2006, n=83 patients) and (2) at the post-outbreak period, after adoption of infection control measures (June 2006, n=31 patients). Forty-one/83 VRE (49.4%) and 3/31(9.7%) VRE were found at the first and second period, respectively. All isolates harbored the vanA gene. In both periods, detection of the gene vanA parallels to the minimum inhibitory concentration values of >256 microg/mL and >48 microg/mL for vancomycin and teicoplanin, respectively. Multiplex PCR and conventional methods agreed in 90.2% for enterococci identification. Besides this accuracy, we also found a remarkable reduction in time to obtain results. Detection of enterococcal species and identification of vancomycin resistance genes were ready in 29.5 hours, in comparison to 72 hours needed by the conventional methods. In conclusion, our protocol identified properly and rapidly enterococci species and vancomycin-resistance genes. The results strongly encourage its adoption by microbiology laboratories for VRE screening in rectal samples.

Entities:  

Mesh:

Year:  2009        PMID: 20231993     DOI: 10.1590/s1413-86702009000400010

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  5 in total

1.  Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study.

Authors:  Alexandre R Marra; Luis Fernando Aranha Camargo; Antonio Carlos Campos Pignatari; Teresa Sukiennik; Paulo Renato Petersen Behar; Eduardo Alexandrino Servolo Medeiros; Julival Ribeiro; Evelyne Girão; Luci Correa; Carla Guerra; Carlos Brites; Carlos Alberto Pires Pereira; Irna Carneiro; Marise Reis; Marta Antunes de Souza; Regina Tranchesi; Cristina U Barata; Michael B Edmond
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

2.  Evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry assisted, selective broth method to screen for vancomycin-resistant enterococci in patients at high risk.

Authors:  Tsi-Shu Huang; Susan Shin-Jung Lee; Chia-Chien Lee; Chiu-Yen Chen; Fang-Chen Chen; Bao-Chen Chen; Cheng Len Sy; Kuan-Sheng Wu
Journal:  PLoS One       Date:  2017-06-13       Impact factor: 3.240

3.  Molecular detection of vanA and vanB genes among vancomycin-resistant enterococci in ICU-hospitalized patients in Ahvaz in southwest of Iran.

Authors:  Mojtaba Moosavian; Hosein Ghadri; Zahra Samli
Journal:  Infect Drug Resist       Date:  2018-11-15       Impact factor: 4.003

4.  Prevalence of vancomycin-resistant enterococcus in Africa in one health approach: a systematic review and meta-analysis.

Authors:  Tsegaye Alemayehu; Mengistu Hailemariam
Journal:  Sci Rep       Date:  2020-11-25       Impact factor: 4.379

5.  Timing of antimicrobial prophylaxis for cesarean section is critical for gut microbiome development in term born infants.

Authors:  Verena Bossung; Mariia Lupatsii; Lkhagvademberel Dashdorj; Oronzo Tassiello; Sinje Jonassen; Julia Pagel; Martin Demmert; Ellinor Anna Wolf; Achim Rody; Silvio Waschina; Simon Graspeuntner; Jan Rupp; Christoph Härtel
Journal:  Gut Microbes       Date:  2022 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.